scholarly article | Q13442814 |
P50 | author | Lisbeth Birk Møller | Q55293524 |
Pawel Grzmil | Q97517997 | ||
P2093 | author name string | Rafał Starzyński | |
Wojciech Krzeptowski | |||
Paweł Lipiński | |||
Małgorzata Lenartowicz | |||
Olga Pierzchała | |||
P2860 | cites work | The Menkes copper transporter is required for the activation of tyrosinase | Q24290551 |
DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells | Q24301418 | ||
Constitutive skipping of alternatively spliced exon 10 in the ATP7A gene abolishes Golgi localization of the menkes protein and produces the occipital horn syndrome | Q24310384 | ||
Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome | Q24539128 | ||
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism | Q24564471 | ||
Neonatal diagnosis and treatment of Menkes disease | Q24626391 | ||
Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy | Q24632623 | ||
A primer for morpholino use in zebrafish. | Q24657663 | ||
Peptidylglycine alpha-amidating monooxygenase: a multifunctional protein with catalytic, processing, and routing domains | Q24675865 | ||
Regulation of brain iron and copper homeostasis by brain barrier systems: implication in neurodegenerative diseases | Q26827257 | ||
Copper signaling in the mammalian nervous system: synaptic effects | Q26849773 | ||
Prenatal treatment of mosaic mice (Atp7a mo-ms) mouse model for Menkes disease, with copper combined by dimethyldithiocarbamate (DMDTC) | Q27335017 | ||
Crystal structure of a copper-transporting PIB-type ATPase | Q27670612 | ||
Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression | Q28215218 | ||
Threshold phenomena versus cell heredity in the manifestation of sex-linked genes in mammals | Q28252259 | ||
A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans | Q28287958 | ||
Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse | Q28297185 | ||
ATP7A-related copper transport diseases-emerging concepts and future trends | Q28302938 | ||
Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis | Q28303981 | ||
Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency | Q28307150 | ||
Zebrafish mutants calamity and catastrophe define critical pathways of gene-nutrient interactions in developmental copper metabolism | Q28473993 | ||
Phenotypic and genetic characterization of the Atp7a(Mo-Tohm) mottled mouse: a new murine model of Menkes disease | Q28507137 | ||
Copper metabolism in mottled mouse mutants. The effect of copper therapy on lysyl oxidase activity in brindled (Mobr) mice | Q42874518 | ||
Phenotypic diversity of Menkes disease in mottled mice is associated with defects in localisation and trafficking of the ATP7A protein | Q43232414 | ||
A comparison of phenotype and copper distribution in blotchy and brindled mutant mice and in nutritionally copper deficient controls | Q43627980 | ||
Epiphyseal growth and osteoarthrosis in blotchy mice | Q43992089 | ||
Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. | Q44814719 | ||
Copper metabolism disorders affect testes structure and gamete quality in male mice | Q45423898 | ||
Developmental expression of the mouse mottled and toxic milk genes suggests distinct functions for the Menkes and Wilson disease copper transporters | Q46047255 | ||
Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease | Q46910599 | ||
Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: implications for iron absorption during early life | Q46955866 | ||
A Drosophila model of Menkes disease reveals a role for DmATP7 in copper absorption and neurodevelopment | Q47070499 | ||
Atp7a determines a hierarchy of copper metabolism essential for notochord development | Q47073635 | ||
Screening of 383 unrelated patients affected with Menkes disease and finding of 57 gross deletions in ATP7A. | Q47367419 | ||
Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. | Q47626958 | ||
Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat. | Q48096862 | ||
Copper metabolism in the macular mutant mouse: an animal model of Menkes's kinky-hair disease | Q48144847 | ||
Clinico-pathological study on macular mutant mouse | Q48233201 | ||
Spectrum of EEG findings in Menkes disease | Q48264247 | ||
Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging | Q48340650 | ||
Epilepsy in Menkes disease: an electroclinical long-term study of 28 patients. | Q48545381 | ||
Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment | Q48611784 | ||
Mutation analysis and expression of the mottled gene in the macular mouse model of Menkes disease | Q48621638 | ||
A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes | Q48638438 | ||
Congenital copper deficiency: copper therapy and dopamine-beta-hydroxylase activity in the mottled (brindled) mouse | Q48709204 | ||
The developmentally regulated expression of Menkes protein ATP7A suggests a role in axon extension and synaptogenesis | Q48791996 | ||
Effects of chelators on copper therapy of macular mouse, a model animal of Menkes' kinky disease | Q48920847 | ||
Markedly reduced activity of lysyl oxidase in skin and aorta from a patient with Menkes' disease showing unusually severe connective tissue manifestations. | Q48930152 | ||
Correction of a mouse model of Menkes disease by the human Menkes gene. | Q51818414 | ||
Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype. | Q52006892 | ||
Effects of oral copper administration to pregnant heterozygous brindled mice on fetal viability and copper levels. | Q52061682 | ||
Localization of Menkes gene expression in the mouse brain; its association with neurological manifestations in Menkes model mice. | Q52203793 | ||
Alternative splicing in the Atp7a gene in the Cu deficient mosaic mutation in mice. | Q52590679 | ||
Expression and localisation of the essential copper transporter DmATP7 in Drosophila neuronal and intestinal tissues. | Q52689144 | ||
Conservation of copper-transporting P(IB)-type ATPase function. | Q52704109 | ||
Functional significance of the copper transporter ATP7 in peptidergic neurons and endocrine cells in Drosophila melanogaster. | Q52743810 | ||
Somatic mosaicism in Menkes disease suggests choroid plexus‐mediated copper transport to the developing brain | Q55220574 | ||
Expression of mRNAs for Lysyl Oxidase and Type III Procollagen in Cultured Fibroblasts from Patients with the Menkes and Occipital Horn Syndromes as Determined by Quantitative Polymerase Chain Reaction | Q57784045 | ||
Menkes' disease: long-term treatment with copper and D-penicillamine | Q67953198 | ||
Copper uptake and transfer to the mouse fetus during pregnancy | Q68199079 | ||
Changes in Tissue Growth, Concentrations of Copper, Iron, Cytochrome Oxidase and Superoxide Dismutase Subsequent to Dietary or Genetic Copper Deficiency in Mice | Q70165068 | ||
Early copper therapy in classic Menkes disease patients with a novel splicing mutation | Q70799318 | ||
Early copper-histidine treatment for Menkes disease | Q70803346 | ||
Cerebellar superoxide dismutase expression in Menkes' kinky hair disease: an immunohistochemical investigation | Q71548382 | ||
Genomic organization of the mottled gene, the mouse homologue of the human Menkes disease gene | Q71784245 | ||
Histochemical localization of copper in the intestine and kidney of macular mice: light and electron microscopic study | Q72620435 | ||
Pathological structure of the kidney from adult mice with mosaic mutation | Q73296028 | ||
Mutation analysis provides additional proof that mottled is the mouse homologue of Menkes' disease | Q73331948 | ||
The mottled mouse as a model for human Menkes disease: identification of mutations in the Atp7a gene | Q73331952 | ||
A serine-to-proline mutation in the copper-transporting P-type ATPase gene of the macular mouse | Q73373497 | ||
Growth of the mouse coat. II. Effect of sex and pregnancy | Q73389506 | ||
Intragenic deletions at Atp7a in mouse models for Menkes disease | Q73957944 | ||
Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients | Q74343383 | ||
Alterations in kidney morphology in mice with mosaic mutation | Q74457920 | ||
Analysis of the distribution of Cu, Fe and Zn and other elements in brindled mouse kidney using a scanning proton microprobe | Q77617347 | ||
Intracellular localization of the Menkes and Wilson's disease proteins and their role in intracellular copper transport | Q78145844 | ||
Urological complications and copper replacement therapy in childhood Menkes syndrome | Q79791842 | ||
Brachial artery aneurysms in Menkes disease | Q80183542 | ||
Identification and analysis of 21 novel disease-causing amino acid substitutions in the conserved part of ATP7A | Q81892365 | ||
Copper | Q83441566 | ||
Effects of copper supplementation on the structure and content of elements in kidneys of mosaic mutant mice | Q84729402 | ||
Menkes disease | Q84844727 | ||
Alterations in the expression of the Atp7a gene in the early postnatal development of the mosaic mutant mice (Atp7amo-ms) – An animal model for Menkes disease | Q85013328 | ||
A sex-linked defect in the cross-linking of collagen and elastin associated with the mottled locus in mice | Q28509236 | ||
Primary defect in copper transport underlies mottled mutants in the mouse | Q28512192 | ||
Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease | Q28513437 | ||
Copper metabolism in mottled mouse mutants. Copper concentrations in tissues during development | Q28513454 | ||
Menkes protein contributes to the function of peptidylglycine alpha-amidating monooxygenase | Q28564470 | ||
Plasma peptidylglycine alpha-amidating monooxygenase (PAM) and ceruloplasmin are affected by age and copper status in rats and mice | Q28569967 | ||
Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro | Q28570556 | ||
Silencing the Menkes copper-transporting ATPase (Atp7a) gene in rat intestinal epithelial (IEC-6) cells increases iron flux via transcriptional induction of ferroportin 1 (Fpn1) | Q28575878 | ||
Copper deficiency in rodents alters dopamine beta-mono-oxygenase activity, mRNA and protein level | Q28580532 | ||
Copper distribution in fetus and placenta of the macular mutant mouse as a model of Menkes kinky hair disease | Q28589426 | ||
Hepatic metallothionein gene expression in toxic milk mice | Q28590566 | ||
Intracellular localization and loss of copper responsiveness of Mnk, the murine homologue of the Menkes protein, in cells from blotchy (Mo blo) and brindled (Mo br) mouse mutants | Q28591479 | ||
Copper-metallothionein in the kidney of macular mice: a model for Menkes disease | Q28594247 | ||
CDD: NCBI's conserved domain database | Q29615740 | ||
X-linked recessive Menkes disease: identification of partial gene deletions in affected males. | Q30332321 | ||
Essential roles in development and pigmentation for the Drosophila copper transporter DmATP7. | Q30476634 | ||
Animal models of Menkes disease | Q33541696 | ||
ATP7A trafficking and mechanisms underlying the distal motor neuropathy induced by mutations in ATP7A. | Q33696716 | ||
Metabolic and molecular bases of Menkes disease and occipital horn syndrome | Q33720831 | ||
Zebrafish models in translational research: tipping the scales toward advancements in human health | Q33814217 | ||
Splice site mutations in the ATP7A gene. | Q33873402 | ||
Menkes disease and infantile epilepsy | Q34021241 | ||
Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment | Q34028117 | ||
Haemolysis and perturbations in the systemic iron metabolism of suckling, copper-deficient mosaic mutant mice - an animal model of Menkes disease. | Q34231704 | ||
Sex chromatin and gene action in the mammalian X-chromosome | Q34263110 | ||
A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration | Q34263233 | ||
The biosynthesis of neuropeptides: peptide alpha-amidation | Q34401086 | ||
Copper, lysyl oxidase, and extracellular matrix protein cross-linking | Q34468104 | ||
Functional copper transport explains neurologic sparing in occipital horn syndrome | Q34582025 | ||
Molecular and biochemical characterization of Mottled-dappled, an embryonic lethal Menkes disease mouse model | Q34657353 | ||
Impact of copper limitation on expression and function of multicopper oxidases (ferroxidases) | Q34729814 | ||
Investigation of iron metabolism in mice expressing a mutant Menke's copper transporting ATPase (Atp7a) protein with diminished activity (Brindled; Mo (Br) (/y) ). | Q34776142 | ||
Molecular correlates of epilepsy in early diagnosed and treated Menkes disease | Q35040602 | ||
X-linked spinal muscular atrophy in mice caused by autonomous loss of ATP7A in the motor neuron | Q35598263 | ||
ATP7A gene addition to the choroid plexus results in long-term rescue of the lethal copper transport defect in a Menkes disease mouse model | Q35623439 | ||
'Am not I a fly like thee?' From genes in fruit flies to behavior in humans | Q35883327 | ||
Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease | Q36088166 | ||
In vivo correction of a Menkes disease model using antisense oligonucleotides | Q36499173 | ||
Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periods | Q36503282 | ||
Lumenal loop M672-P707 of the Menkes protein (ATP7A) transfers copper to peptidylglycine monooxygenase | Q36631826 | ||
L-threo-dihydroxyphenylserine corrects neurochemical abnormalities in a Menkes disease mouse model | Q36684997 | ||
Copper homeostasis gene discovery in Drosophila melanogaster. | Q36704720 | ||
Mutations in the murine homologue of the Menkes gene in dappled and blotchy mice | Q36736489 | ||
Function and regulation of human copper-transporting ATPases | Q36872228 | ||
Metabolic crossroads of iron and copper | Q36948822 | ||
Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins | Q37000460 | ||
Peptidylgycine α-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function | Q37066112 | ||
Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis | Q37112824 | ||
Copper transport to the brain by the blood-brain barrier and blood-CSF barrier | Q37181841 | ||
Molecular diagnosis of Menkes disease: genotype-phenotype correlation. | Q37509970 | ||
Hepcidin, the iron watcher | Q37531144 | ||
Peptidylglycine α-amidating monooxygenase heterozygosity alters brain copper handling with region specificity | Q37610172 | ||
Posttranslational regulation of copper transporters | Q37610865 | ||
Structural organization of human Cu-transporting ATPases: learning from building blocks | Q37620222 | ||
Copper handling machinery of the brain | Q37808945 | ||
Pathology, clinical features and treatments of congenital copper metabolic disorders – Focus on neurologic aspects | Q37812879 | ||
An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome. | Q38071046 | ||
Understanding copper sensitivity in zebrafish (Danio rerio) through the intracellular localization of copper transporters in a hepatocyte cell-line ZFL and the tissue expression profiles of copper transporters. | Q39012778 | ||
Distinct functional roles for the Menkes and Wilson copper translocating P-type ATPases in human placental cells. | Q40058916 | ||
Epilepsy in Menkes disease: analysis of clinical stages. | Q40485488 | ||
Copper homoeostasis in Drosophila melanogaster S2 cells | Q40538435 | ||
Type IX Ehlers-Danlos syndrome and Menkes syndrome: the decrease in lysyl oxidase activity is associated with a corresponding deficiency in the enzyme protein. | Q40611941 | ||
Recent developments in Menkes disease | Q40865090 | ||
The mottled gene is the mouse homologue of the Menkes disease gene | Q41037716 | ||
Similar splicing mutations of the Menkes/mottled copper-transporting ATPase gene in occipital horn syndrome and the blotchy mouse. | Q41863725 | ||
Instability of superoxide dismutase 1 of Drosophila in mutants deficient for its cognate copper chaperone | Q41885677 | ||
Comparisons of copper deficiency states in the murine mutants blotchy and brindled. Changes in copper-dependent enzyme activity in 13-day-old mice | Q41940659 | ||
Multiple regulatory mechanisms act in concert to control ferroportin expression and heme iron recycling by macrophages | Q42629549 | ||
Copper-trafficking efficacy of copper-pyruvaldehyde bis(N4- methylthiosemicarbazone) on the macular mouse, an animal model of Menkes disease | Q42717308 | ||
Effect of copper and disulfiram combination therapy on the macular mouse, a model of Menkes disease | Q42717689 | ||
Mutation in the CPC motif-containing 6th transmembrane domain affects intracellular localization, trafficking and copper transport efficiency of ATP7A protein in mosaic mutant mice--an animal model of Menkes disease | Q42723820 | ||
PCR-cloning of tilapia ATP7A cDNA and its mRNA levels in tissues of tilapia following copper administrations. | Q42725979 | ||
Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin | Q42743122 | ||
Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila | Q42744115 | ||
Zebrafish sod1 and sp1 expression are modulated by the copper ATPase gene atp7a in response to intracellular copper status | Q42776376 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Menkes disease | Q639203 |
P304 | page(s) | 72 | |
P577 | publication date | 2015-01-01 | |
P1433 | published in | Frontiers in Molecular Neuroscience | Q27721913 |
P1476 | title | Mottled Mice and Non-Mammalian Models of Menkes Disease | |
P478 | volume | 8 |
Q39038980 | Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling |
Q87856800 | Animal models of Wilson disease |
Q47935607 | Atp7a and Atp7b regulate copper homeostasis in developing male germ cells in mice. |
Q47408660 | Copper and Zinc Homeostasis: Lessons from Drosophila melanogaster |
Q57168299 | Disulfiram enhanced delivery of orally administered copper into the central nervous system in Menkes disease mouse model |
Q26738363 | Menkes disease: what a multidisciplinary approach can do |
Q55235450 | Metabolic etiologies in West syndrome. |
Q51735978 | Multimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease. |
Q48120135 | Neurotoxicity of Copper. |